Induction of Intercellular Adhesion Molecule-1 on Human Brain Endothelial Cells by HIV-1 gp120: Role of CD4 and Chemokine Coreceptors

Laboratory Investigation

Volumn 83, Issue 12, 2003, Pages 1787-1798

  Stins, Monique F ^a   Pearce, Donna ^a   Di Cello, Francescopaolo ^a   Erdreich Epstein, Anat ^b   Pardo, Carlos A ^a   Kim, Kwang Sik ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CD4 ANTIGEN; CHEMOKINE RECEPTOR; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; PERTUSSIS TOXIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BRAIN CELL; CELL ACTIVATION; CELL CULTURE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOREGULATION; INHIBITION KINETICS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANTIBODIES, BLOCKING; ANTIGENS, CD4; CELLS, CULTURED; CHILD; ENDOTHELIUM, VASCULAR; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICROCIRCULATION; NF-KAPPA B; NITRILES; ORGANIC CHEMICALS; PERTUSSIS TOXIN; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONES;

EID: 0347364748     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000107008.13321.C8     Document Type: Article

References (85)

1. Andjelkovic AV and Pachter JS (2000). Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels. J Neurochem 75:1898-1906.
2. Annunziata P, Cioni C, Toneatto S, and Paccagnini E (1998). HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P. AIDS 12:2377-2385.
3. Banks WA, Kastin AJ, and Akerstrom V (1997). HIV-1 protein gp120 crosses the blood-brain barrier: Role of adsorptive endocytosis. Life Sci 61:L119-L125.
4. Baribaud F, Edwards TG, Sharron M, Brelot A, Heveker N, Price K, Mortad F, Alizon M, Tsang M, and Doms RW (2001). Antigenically distinct conformations of CXCR4. J Virol 75: 8957-8967.
5. Berger JR, Moskowitz L, Fischl M, and Kelley RE (1987). Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J 80:683-686.
6. Berger JR, Nath A, Greenberg RN, Andersen AH, Greene RA, Bognar A, and Avison MJ (2000). Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology 54:921-926.
7. Berger O, Gan X, Gujuluva C, Burns AR, Sulur G, Stins M, Way D, Witte M, Weinand M, Said J, Kim KS, Taub D, Graves MC, and Fiala M (1999). CXC and CC chemokine receptors on coronary and brain endothelia. Mol Med 5:795-805.
8. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, and Springer TA (1996). The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-833.
9. Brelot A, Heveker N, Montes M, and Alizon M (2000). Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities. J Biol Chem 275:23736-23744.
10. Buttner A, Mehraein P, and Weis S (1996). Vascular changes in the cerebral cortex in HIV-1 infection. II. An immunohistochemical and lectinhistochemical investigation. Acta Neuropathol (Berl) 92:35-41.
11. Capobianchi MR (1996). Induction of lymphomonocyte activation by HIV-1 glycoprotein gp120. Possible role in AIDS pathogenesis. J Biol Regul Homeost Agents 10:83-91.
12. Catani MV, Corasaniti MT, Navarra M, Nistico G, Finazzi-Agro A, and Melino G (2000). gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem 74:2373-2379.
13. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J (1996). The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
14. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, and Maniatis T (1995). Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 9:899-909.
15. Craig LE, Spelman JP, Strandberg JD, and Zink MC (1998). Endothelial cells from diverse tissues exhibit differences in growth and morphology. Microvasc Res 55:65-76.
16. Da Cunha A, Jackson RW, and Vitkovic L (1995). HIV-1 non-specifically stimulates production of transforming growth factor-beta 1 transfer in primary astrocytes. J Neuroimmunol 60:125-133.
17. Davis CB, Dikic I, Unutmaz D, Hill CM, Arthos J, Siani MA, Thompson DA, Schlessinger J, and Littman DR (1997). Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 186:1793-1798.
18. Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, and Sweet RW (1988). A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331:82-84.
19. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR, and Landau NR (1996). Identification of a major co-receptor for primary isolates of HIV-1 [see comments]. Nature 381:661-666.
20. Dimitrov DS, Norwood D, Stantchev TS, Feng Y, Xiao X, and Broder CC (1999). A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages. Virology 259:1-6.
21. Doranz BJ, Berson JF, Rucker J, and Doms RW (1997a). Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1). Immunol Res 16:15-28.
22. Doranz BJ, Lu ZH, Rucker J, Zhang TY, Sharron M, Cen YH, Wang ZX, Guo HH, Du JG, Accavitti MA, Doms RW, and Peiper SC (1997b). Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J Virol 71:6305-6314.
23. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, Cayanan C, Maddon PJ, Koup RA, Moore JP, and Paxton WA (1996). HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC- CKR-5 [see comments]. Nature 381:667-673.
24. Edinger AL, Mankowski JL, Doranz BJ, Margulies BJ, Lee B, Rucker J, Sharron M, Hoffman TL, Berson JF, Zink MC, Hirsch VM, Clements JE, and Doms RW (1997). CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci USA 94:14742-14747.
25. Fantini J, Hammache D, Pieroni G, and Yahi N (2000). Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion. Glycoconj J 17:199-204.
26. Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, Gerard NP, Gerard C, Sodroski J, and Choe H (1999). Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96:667-676.
27. Feng Y, Broder CC, Kennedy PE, and Berger EA (1996). HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor [see comments]. Science 272:872-877.
28. Fiala M, Looney DJ, Stins M, Way DD, Zhang L, Gan X, Chiappelli F, Schweitzer ES, Shapshak P, Weinand M, Graves MC, Witte M, and Kim KS (1997). TNF-alpha opens a paracellular route for HIV-1 invasion across the blood-brain barrier. Mol Med 3:553-564.
29. Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, and Kupfer A (1995). Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes [see comments]. Nat Med 1:129-134.
30. Gaddi E, Laucella S, Balbaryski J, Cantisano C, Barboni G, Candi M, and Giraudi V (2000). Prognostic value of soluble intercellular adhesion molecule-1 (s-ICAM-1) in HIV-infected children. Scand J Immunol 52:628-633.
31. Hesselgesser J, Taub D, Baskar P, Greenberg M, Hoxie J, Kolson DL, and Horuk R (1998). Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 8:595-598.
32. Hildreth JE and Orentas RJ (1989). Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244:1075-1078.
33. Huang MB, Khan M, Garcia-Barrio M, Powell M, and Bond VC (2001). Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120. J Acquir Immune Defic Syndr 27:213-221.
34. Ilyin SE and Plata-Salaman CR (1997). HIV-1 envelope glycoprotein 120 regulates brain IL-1beta system and TNF-alpha mRNAs in vivo. Brain Res Bull 44:67-73.
35. Kumar S, West DC, and Ager A (1987). Heterogeneity in endothelial cells from large vessels and microvessels. Differentiation 36:57-70.
36. Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan-Vague I, and Gastaut JA (1992). Endothelial cell dysfunction in HIV infection. J Acquir Immune Defic Syndr 5:127-131.
37. Lannuzel A, Barnier JV, Hery C, Huynh VT, Guibert B, Gray F, Vincent JD, and Tardieu M (1997). Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen-activated protein kinases in human neurons. Ann Neurol 42:847-856.
38. Lavi E, Strizki JM, Ulrich AM, Zhang W, Fu L, Wang Q, O'Connor M, Hoxie JA, and Gonzalez-Scarano F (1997). CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol 151:1035-1042.
39. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, and Hildreth JE (2001). Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 17:1009-1019.
40. Liu NQ, Lossinsky AS, Popik W, Li X, Gujuluva C, Kriederman B, Roberts J, Pushkarsky T, Bukrinsky M, Witte M, Weinand M, and Fiala M (2002). Human immunodeficiency virus type 1 enters brain microvascular endothelia by micropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol 76:6689-6700.
41. Lu Z, Berson JF, Chen Y, Turner JD, Zhang T, Sharron M, Jenks MH, Wang Z, Kim J, Rucker J, Hoxie JA, Peiper SC, and Doms RW (1997). Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc Natl Acad Sci U S A 94:6426-6431.
42. MacLean AG, Orandle MS, Alvarez X, Williams KC, and Lackner AA (2001). Rhesus macaque brain microvessel endothelial cells behave in a manner phenotypically distinct from umbilical vein endothelial cells. J Neuroimmunol 118: 223-232.
43. Mankowski JL, Queen SE, Kirstein LM, Spelman JP, Laterra J, Simpson IA, Adams RJ, Clements JE, and Zink MC (1999). Alterations in blood-brain barrier glucose transport in SIV-infected macaques. J Neurovirol 5:695-702.
44. Mbemba E, Benjouad A, Saffar L, and Gattegno L (1999). Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells. Virology 265:354-364.
45. McCallus DE, Ugen KE, Sato AI, Williams WV, and Weiner DB (1992). Construction of a recombinant bacterial human CD4 expression system producing a bioactive CD4 molecule. Viral Immunol 5:163-172.
46. McCutchan FE, Hegerich PA, Brennan TP, Phanuphak P, Singharaj P, Jugsudee A, Berman PW, Gray AM, Fowler AK, and Burke DS (1992). Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses 8:1887-1895.
47. Molitor JA, Walker WH, Doerre S, Ballard DW, and Greene WC (1990). NF-kappa B: A family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci U S A 87:10028-10032.
48. Mondor I, Ugolini S, and Sattentau QJ (1998). Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J Virol 72:3623-3634.
49. Moses AV, Bloom FE, Pauza CD, and Nelson JA (1993). Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci USA 90:10474-10478.
50. Most J, Zangerle R, Herold M, Fuchs D, Wachter H, Fritsch P, and Dierich MP (1993). Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) in HIV-1 infection. J Acquir Immune Defic Syndr 6:221-226.
51. Mukhtar M, Harley S, Chen P, BouHamdan M, Patel C, Acheampong E, and Pomerantz RJ (2002). Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN. Virology 297:78-88.
52. Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, Sharer LR, McComb RD, Swindells S, Soderland C, and Gendelman HE (1996). Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 156:1284-1295.
53. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, and Moser B (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382: 833-835.
54. Patel M, Yanagishita M, Roderiquez G, Bou-Habib DC, Oravecz T, Hascall VC, and Norcross MA (1993). Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retroviruses 9:167-174.
55. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, and Fiala M (1997). A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol 158:3499-3510.
56. Persidsky Y, Zheng J, Miller D, and Gendelman HE (2000). Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68:413-422.
57. Petito CK and Cash KS (1992). Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 32:658-666.
58. Poland SD, Rice GP, and Dekaban GA (1995). HIV-1 infection of human brain-derived microvascular endothelial cells in vitro. J Acquir Immune Defic Syndr Hum Retrovirol 8:437-445.
59. Posner MR, Cavacini LA, Emes CL, Power J, and Byrn R (1993). Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120. J Acquir Immune Defic Syndr 6:7-14.
60. Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, and Trapp BD (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann Neurol 34:339-350.
61. Prasadarao NV, Wass CA, Hacker J, Jann K, and Kim KS (1993). Adhesion of S-fimbriated Escherichia coli to brain glycolipids mediated by sfaA gene-encoded protein of S-fimbriae. J Biol Chem 268:10356-10363.
62. Ren Z, Yao Q, and Chen C (2002). HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells. Lab Invest 82:245-255.
63. Rhodes RH (1991). Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J Neuropathol Exp Neurol 50:171-183.
64. Rieckmann P, Nunke K, Burchhardt M, Albrecht M, Wiltfang J, Ulrich M, and Felgenhauer K (1993). Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: An indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. J Neuroimmunol 47:133-140.
65. Rolinski B, Geier SA, Sadri I, Klauss V, Bogner JR, Ehrenreich H, and Goebel FD (1994). Endothelin-1 immunoreactivity in plasma is elevated in HIV-1 infected patients with retinal microangiopathic syndrome. Clin Invest 72:288-293.
66. Sasseville VG, Newman WA, Lackner AA, Smith MO, Lausen NC, Beall D, and Ringler DJ (1992). Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus. Am J Pathol 141:1021-1030.
67. Schecter AD, Berman AB, Yi L, Mosoian A, McManus CM, Berman JW, Klotman ME, and Taubman MB (2001). HIV envelope gp120 activates human arterial smooth muscle cells. Proc Natl Acad Sci USA 98:10142-10147.
68. Scheglovitova O, Scanio V, Fais S, Papadia S, Abbate I, Castilletti C, Dianzani F, and Capobianchi MR (1995). Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells. Arch Virol 140:951-958.
69. Schreiber E, Matthias P, Muller MM, and Schaffner W (1989). Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res 17:6419.
70. Schved JF, Gris JC, Arnaud A, Martinez P, Sanchez N, Wautier JL, and Sarlat C (1992). von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: Independent prognostic relevance of tissue-type plasminogen activator. J Lab Clin Med 120:411-419.
71. Seigneur M, Constans J, Blann A, Renard M, Pellegrin JL, Amiral J, Boisseau M, and Conri C (1997). Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost 77:646-649.
72. Seilhean D, Dzia-Lepfoundzou A, Sazdovitch V, Cannella B, Raine CS, Katlama C, Bricaire F, Duyckaerts C, and Hauw JJ (1997). Astrocytic adhesion molecules are increased in HIV-1-associated cognitive/motor complex. Neuropathol Appl Neurobiol 23:83-92.
73. Shrikant P, Benos DJ, Tang LP, and Benveniste EN (1996). HIV glycoprotein 120 enhances intercellular adhesion molecule-1 gene expression in glial cells. Involvement of Janus kinase/signal transducer and activator of transcription and protein kinase C signaling pathways. J Immunol 156: 1307-1314.
74. Stins MF, Gilles F, and Kim KS (1997). Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 76:81-90.
75. Stins MF, Shen Y, Huang SH, Gilles F, Kalra VK, and Kim KS (2001). Gp120 activates children's brain endothelial cells via CD4. J Neurovirol 7:1-10.
76. Tamamura H, Omagari A, Hiramatsu K, Gotoh K, Kanamoto T, Xu Y, Kodama E, Matsuoka M, Hattori T, Yamamoto N, Nakashima H, Otaka A, and Fujii N (2001). Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140. Bioorg Med Chem Lett 11:1897-1902.
77. Toneatto S, Finco O, van der PH, Abrignani S, and Annunziata P (1999). Evidence of blood-brain barrier alteration and activation in HIV-1 gp120 transgenic mice. AIDS 13:2343-2348.
78. Ugen KE (1993). Generation of antibodies against the aminoterminus of gp120 that elicit antibody-dependent cellular cytotoxicity. In: Refaeli Y, Ziegner U, Agadyanan M, Satre MA, Srikantan V, Wang B, Sato A, Williams WV, and Weiner DB, editors. Vaccines 93. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 215-221.
79. Ullrich CK, Groopman JE, and Ganju RK (2000). HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases. Blood 96:1438-1442.
80. van de SA and van der Saag PT (1996). Intercellular adhesion molecule-1. J Mol Med 74:13-33.
81. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, and Farrar WL (1989). Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci USA 86:621-625.
82. Wang ZX, Berson JF, Zhang TY, Cen YH, Sun Y, Sharron M, Lu ZH, and Peiper SC (1998). CXCR4 sequences involved in coreceptor determination of human immunodeficiency virus type-1 tropism. Unmasking of activity with M-tropic Env glycoproteins. J Biol Chem 273:15007-15015.
83. Weis S, Haug H, and Budka H (1996). Vascular changes in the cerebral cortex in HIV-1 infection. I. A morphometric investigation by light and electron microscopy. Clin Neuropathol 15:361-366.
84. Wong D and Dorovini-Zis K (1992). Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J Neuroimmunol 39:11-21.
85. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, and Mackay CR (1997). CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 185:1681-1691.